Table 3.
OSCC Samples (n=206) |
Control Samples (n=134) |
|||
---|---|---|---|---|
No. of Patients | % | No. of Patients | % | |
HPV16 IgG | ||||
Positive | 197 | 95.6 | 89 | 66.4 |
Negative | 9 | 4.4 | 45 | 33.6 |
HPV16 IgM | ||||
Positive | 42 | 20.4 | 0 | 0 |
Negative | 164 | 79.6 | 134 | 100 |
OSCC Samples (n=206) |
Control Samples (n=134) |
|||
---|---|---|---|---|
No. of Patients | % | No. of Patients | % | |
HPV16 IgG | ||||
Positive | 197 | 95.6 | 89 | 66.4 |
Negative | 9 | 4.4 | 45 | 33.6 |
HPV16 IgM | ||||
Positive | 42 | 20.4 | 0 | 0 |
Negative | 164 | 79.6 | 134 | 100 |